MRI-negative myelitis, especially after COVID-19: a case report and literature review
In post-COVID-19 MRI-negative myelitis, SEPs offer critical diagnostic and prognostic information. Early recognition and timely escalation of combination immunotherapy may optimize neurological outcomes.
Authors
- Kazumoto Shibuya (ORCID: https://orcid.org/0000-0003-4061-0412)
- Mitsuyoshi Tamura (ORCID: https://orcid.org/0000-0002-7794-0602)
- Masahiro Mori (ORCID: https://orcid.org/0000-0002-8767-255X)
- Hiroki Masuda (ORCID: https://orcid.org/0000-0002-4106-6482)
- Satoko Yoshizaki
- Y. Yagi
- Satoki Hanayama
Institutions
- Chiba University (JP)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2025-12-10
- DOI
- https://doi.org/10.3389/fimmu.2025.1708018
- Primary Topic
- Long-Term Effects of COVID-19
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Jikei University School of Medicine